{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:05:51Z","timestamp":1788437151211,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Canadian Institutes of Health Research (CIHR)","award":["106665"],"award-info":[{"award-number":["106665"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.taap.2015.10.003","type":"journal-article","created":{"date-parts":[[2015,10,21]],"date-time":"2015-10-21T04:55:49Z","timestamp":1445403349000},"page":"550-559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["19-Hydroxyeicosatetraenoic acid and isoniazid protect against angiotensin II-induced cardiac hypertrophy"],"prefix":"10.1016","volume":"289","author":[{"given":"Samya","family":"Elkhatali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"El-Sherbeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama H.","family":"Elshenawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada","family":"Abdelhamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman O.S.","family":"El-Kadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2015.10.003_bb0010","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1073\/pnas.0811022106","article-title":"Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy","volume":"106","author":"Ai","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2015.10.003_bb0015","first-page":"F790","article-title":"20-HETE agonists and antagonists in the renal circulation","volume":"277","author":"Alonso-Galicia","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.taap.2015.10.003_bb0025","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1111\/bph.12066","article-title":"Soluble epoxide hydrolase inhibitor, TUPS, protects against isoprenaline-induced cardiac hypertrophy","volume":"168","author":"Althurwi","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2015.10.003_bb0030","doi-asserted-by":"crossref","DOI":"10.3109\/00498254.2012.754113","article-title":"Acute arsenic treatment alters cytochrome P450 expression and arachidonic acid metabolism in lung, liver and kidney of C57Bl\/6 mice","author":"Anwar-Mohamed","year":"2013","journal-title":"Xenobiotica"},{"key":"10.1016\/j.taap.2015.10.003_bb0035","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.phrs.2009.12.015","article-title":"Alteration of cardiac cytochrome P450-mediated arachidonic acid metabolism in response to lipopolysaccharide-induced acute systemic inflammation","volume":"61","author":"Anwar-Mohamed","year":"2010","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.taap.2015.10.003_bb0040","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0024-3205(01)01241-3","article-title":"L-NAME prevents in vivo the inactivation but not the down-regulation of hepatic cytochrome P450 caused by an acute inflammatory reaction","volume":"69","author":"Barakat","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.taap.2015.10.003_bb0045","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.ehj.2004.06.038","article-title":"Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure. The Rotterdam Study","volume":"25","author":"Bleumink","year":"2004","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.taap.2015.10.003_bb0050","doi-asserted-by":"crossref","first-page":"5362","DOI":"10.1073\/pnas.78.9.5362","article-title":"Liver microsomal cytochrome P-450 and the oxidative metabolism of arachidonic acid","volume":"78","author":"Capdevila","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2015.10.003_bb0055","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0022-2275(20)32049-6","article-title":"Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase","volume":"41","author":"Capdevila","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.taap.2015.10.003_bb0060","doi-asserted-by":"crossref","first-page":"H1018","DOI":"10.1152\/ajpheart.01172.2007","article-title":"20-Hydroxyeicosatetraenoic acid causes endothelial dysfunction via eNOS uncoupling","volume":"294","author":"Cheng","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.taap.2015.10.003_bb0065","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1042\/cs0980277","article-title":"Cytochrome P450 metabolites of arachidonic acid may be important mediators in angiotensin II-induced vasoconstriction in the rat mesentery in vivo","volume":"98","author":"Chu","year":"2000","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.taap.2015.10.003_bb0070","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0891-5849(99)00034-9","article-title":"Arachidonic acid interaction with the mitochondrial electron transport chain promotes reactive oxygen species generation","volume":"27","author":"Cocco","year":"1999","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.taap.2015.10.003_bb0080","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/AAC.45.2.382-392.2001","article-title":"Inhibition of cytochrome P450 (CYP450) isoforms by isoniazid: potent inhibition of CYP2C19 and CYP3A","volume":"45","author":"Desta","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.taap.2015.10.003_bb0085","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.bcp.2013.11.015","article-title":"Alterations in cytochrome P450-derived arachidonic acid metabolism during pressure overload-induced cardiac hypertrophy","volume":"87","author":"El-Sherbeni","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2015.10.003_bb0090","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1124\/dmd.114.057836","article-title":"Characterization of arachidonic acid metabolism by rat cytochrome P450 enzymes: the involvement of CYP1As","volume":"42","author":"El-Sherbeni","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2015.10.003_bb0095","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.pharmthera.2005.05.011","article-title":"Cytochrome P450 enzymes: central players in cardiovascular health and disease","volume":"112","author":"Elbekai","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.taap.2015.10.003_bb0100","doi-asserted-by":"crossref","first-page":"706","DOI":"10.2174\/1389200211314060007","article-title":"20-Hydroxyeicosatetraenoic acid is a potential therapeutic target in cardiovascular diseases","volume":"14","author":"Elshenawy","year":"2013","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.taap.2015.10.003_bb0105","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1097\/HJH.0b013e3283546719","article-title":"Prevalence of left-ventricular hypertrophy by multiple electrocardiographic criteria in general population: Hermex study","volume":"30","author":"Felix-Redondo","year":"2012","journal-title":"J. Hypertens."},{"key":"10.1016\/j.taap.2015.10.003_bb0115","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/hrt.2005.083949","article-title":"Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme","volume":"93","author":"Hawkins","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.taap.2015.10.003_bb0120","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1161\/HYPERTENSIONAHA.110.154518","article-title":"Cytochrome P450 1B1 contributes to angiotensin II-induced hypertension and associated pathophysiology","volume":"56","author":"Jennings","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.taap.2015.10.003_bb0125","doi-asserted-by":"crossref","first-page":"9886","DOI":"10.1073\/pnas.91.21.9886","article-title":"Effects of long-chain polyunsaturated fatty acids on the contraction of neonatal rat cardiac myocytes","volume":"91","author":"Kang","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2015.10.003_bb0130","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1073\/pnas.92.9.3997","article-title":"Free, long-chain, polyunsaturated fatty acids reduce membrane electrical excitability in neonatal rat cardiac myocytes","volume":"92","author":"Kang","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2015.10.003_bb0135","doi-asserted-by":"crossref","first-page":"12912","DOI":"10.1016\/S0021-9258(18)31472-8","article-title":"Formation of 19(S)-, 19(R)-, and 18(R)-hydroxyeicosatetraenoic acids by alcohol-inducible cytochrome P450 2E1","volume":"268","author":"Laethem","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2015.10.003_bb0140","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212delta delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.taap.2015.10.003_bb0145","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2015.10.003_bb0150","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1124\/dmd.32.7.727","article-title":"The effect of isoniazid on CYP2E1- and CYP4A-mediated hydroxylation of arachidonic acid in the rat liver and kidney","volume":"32","author":"Poloyac","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2015.10.003_bb0155","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1161\/CIR.0b013e31823ac046","article-title":"Heart disease and stroke statistics\u20142012 update: a report from the American Heart Association","volume":"125","author":"Roger","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.taap.2015.10.003_bb0160","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1152\/physrev.00021.2001","article-title":"P-450 metabolites of arachidonic acid in the control of cardiovascular function","volume":"82","author":"Roman","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.taap.2015.10.003_bb0165","doi-asserted-by":"crossref","first-page":"R917","DOI":"10.1152\/ajpregu.00395.2012","article-title":"Antioxidant-based therapies for angiotensin II-associated cardiovascular diseases","volume":"304","author":"Rosenbaugh","year":"2013","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.taap.2015.10.003_bb0170","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/hrt.77.1.24","article-title":"Associations between circulating components of the renin\u2013angiotensin\u2013aldosterone system and left ventricular mass","volume":"77","author":"Schunkert","year":"1997","journal-title":"Heart"},{"key":"10.1016\/j.taap.2015.10.003_bb0175","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0952-3278(97)90497-X","article-title":"Accumulation of arachidonic acid in ischemic\/reperfused cardiac tissue: possible causes and consequences","volume":"57","author":"Van der Vusse","year":"1997","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.taap.2015.10.003_bb0180","first-page":"494","article-title":"Effects of rifampicin on pharmacokinetics of isoniazid and its metabolite acetylhydrazine in rats","volume":"13","author":"Zhang","year":"1992","journal-title":"Zhongguo Yao Li Xue Bao"},{"key":"10.1016\/j.taap.2015.10.003_bb0185","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1124\/dmd.108.023077","article-title":"Modulation of cytochrome P450 gene expression and arachidonic acid metabolism during isoproterenol-induced cardiac hypertrophy in rats","volume":"36","author":"Zordoky","year":"2008","journal-title":"Drug Metab. Dispos."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X1530106X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X1530106X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T20:00:46Z","timestamp":1653336046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X1530106X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0041008X1530106X"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2015.10.003","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"19-Hydroxyeicosatetraenoic acid and isoniazid protect against angiotensin II-induced cardiac hypertrophy","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2015.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}